Angiogenesis: High-dose aflibercept demonstrates safety, efficacy in treatment of DMEFebruary 28th 2023
David S. Boyer, MD, presented data from the PHOTON study examining the safety and efficacy of high-dose aflibercept for treatment of diabetic macular edema at the 2023 Angiogenesis, Exudation, and Degeneration conference.
APAO 2023: Keralink Trial and efficacy safety of corneal cross-linking for children with KeratoconusFebruary 25th 2023
The Keralink Trial was the first randomized clinical trial that tested the hypothesis that corneal cross-linking (CXL) might decrease keratoconus progression in children compared with the use of spectacles or contact lenses.
APAO 2023: Probe with beveled tip offers surgeons an all-in-one instrument for retinal detachment vitrectomyFebruary 24th 2023
Yusuke Oshima, MD, PhD, in a presentation at the 38th Asia-Pacific Academy of Ophthalmology Congress, Kuala Lumpur, Malaysia, discussed the advantages of using a beveled-tip ultra-speed probe for complete vitreous shaving during retinal detachment vitrectomies.
APAO 2023: Study finds diffuse atrophy in children may be path to development of pathologic myopia in adultsFebruary 24th 2023
In a presentation at the Asia-Pacific Academy of Ophthalmology Congress in Kuala Lumpur, Malaysia, Kyoko Ohno-Matsui, MD, PhD, noted that changes of scleral curvature and staphyloma edge development may occur in synchronicity.
Angiogenesis 2023: Dry AMD and ellipsoid zone integrityFebruary 11th 2023
In a presentation at the Angiogenesis, Exudation, and Degeneration 2023 conference, Justis Ehlers, MD, presented "Ellipsoid Zone Integrity in Dry AMD: An Imaging Biomarker for Progression Risk and Clinical Trial Endpoint.”
Angiogenesis 2023: Uncovering the mystery surrounding geographic atrophyFebruary 10th 2023
In a presentation at the 2023 Angiogenesis, Exudation, and Degeneration program, Usha Chakravarthy, PhD, FRCOphth, CBE, presented data from the trial of lampalizumab, which is peeling back some of the mystery shrouding geographic atrophy.
Angiogenesis 2023: Investigators explore use of ophthalmic artery angioplasty to treat AMDFebruary 10th 2023
In a presentation at Bascom Palmer’s 2023 Angiogenesis, Exudation, and Degeneration conference in Miami, Pedro Lylyk, MD, said ophthalmic artery angioplasty could prove to be a treatment option for patients diagnosed with age-related macular degeneration.
The pathophysiology and pathomorphology of corneal ectasia: Part 4November 14th 2022
Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.
Assessing barriers to retinal care during a pandemicNovember 2nd 2022
A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Systemic factors not predictive of VA outcomes following cataract surgery in patients with diabetic retinopathyOctober 29th 2022
Investigators evaluated VA outcomes after cataract surgery and the factors associated with good visual outcomes in a population of patients with type 2 diabetes.